EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Case Report: Alternative biopsy targets plus CEUS-guided omental puncture: enabling CLDN18.2 detection and precision therapy enrollment in pancreatic cancer

Hang Yin, Xiaomeng Zhang, Bing Song, Hui Li, Kun Liu, Chengzheng Zhang

Frontiers in Radiology · 15.07.2026 · 6

DOI: 10.3389/fradi.2026.1800543 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Radiology, online erschienen am 15.07.2026. Verfasst von Hang Yin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Jining Medical University, Jining, Shandong, China. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Some primary pancreatic cancer lesions are located deep in the abdomen and adjacent to major blood vessels, which leads to procedural risk and low success rates of percutaneous biopsy. This situation creates substantial obstacles for pathological diagnosis and biomarker detection.

Methods

We present a 54-year-old female patient diagnosed with malignant pancreatic body carcinoma. The primary tumor was in close proximity to the splenic artery and accompanied by omental metastatic nodules. After multidisciplinary team discussion, we selected the safely accessible omental metastatic lesions as alternative biopsy targets and performed core needle biopsy under contrast-enhanced ultrasound (CEUS) guidance for tissue sampling.

Results

Pathological examination confirmed adenocarcinoma, and the immunophenotype was consistent with a pancreatobiliary origin. Immunohistochemical staining revealed high CLDN18.2 expression. The patient was subsequently enrolled in a clinical trial for CLDN18.2-directed combination therapy. Serial imaging follow-up demonstrated measurable shrinkage of both the primary tumor and metastatic lesions.

Discussion

When imaging and clinical evaluations strongly indicate a solitary pancreatic malignancy and safely accessible metastatic lesions are present, the strategy of CEUS-guided alternative target biopsy serves as a viable approach to acquire tissue specimens and conduct biomarker testing. Nonetheless, its diagnostic concordance and clinical generalizability remain to be validated in large-sample studies.

Schlagwörter

Stichwörter der Autor:innen

CLDN18.2alternative biopsy targetsinterventional ultrasoundpancreatic cancertargeted therapy

Autor:innen und Institutionen

  • Jining Medical University, Jining, Shandong, China.
  • Department of Ultrasound, Affiliated Hospital of Jining Medical University, Jining, Shandong, China.

Zitieren

APA

Yin, H., Zhang, X., Song, B., Li, H., Liu, K., & Zhang, C. (2026). Case Report: Alternative biopsy targets plus CEUS-guided omental puncture: enabling CLDN18.2 detection and precision therapy enrollment in pancreatic cancer. Frontiers in Radiology, 6. https://doi.org/10.3389/fradi.2026.1800543

Vancouver

Yin H, Zhang X, Song B, Li H, Liu K, Zhang C. Case Report: Alternative biopsy targets plus CEUS-guided omental puncture: enabling CLDN18.2 detection and precision therapy enrollment in pancreatic cancer. Frontiers in Radiology. 2026;6. doi:10.3389/fradi.2026.1800543

BibTeX
@article{Yin2026,
  author = {Yin, Hang and Zhang, Xiaomeng and Song, Bing and Li, Hui and Liu, Kun and Zhang, Chengzheng},
  title = {Case Report: Alternative biopsy targets plus CEUS-guided omental puncture: enabling CLDN18.2 detection and precision therapy enrollment in pancreatic cancer},
  journal = {Frontiers in Radiology},
  year = {2026},
  volume = {6},
  doi = {10.3389/fradi.2026.1800543}
}
Kostenlos starten →